Analysts’ Updated EPS Estimates for March 6th (ADT, AES, AIR, AMPX, AVBP, AVTR, BRLT, CERT, COOK, COST)

Analysts’ updated eps estimates for Friday, March 6th:

ADT (NYSE:ADT) had its underweight rating reaffirmed by analysts at Barclays PLC. They currently have a $7.00 target price on the stock.

AES (NYSE:AES) had its equal weight rating reiterated by analysts at Morgan Stanley. They currently have a $15.00 price target on the stock, down from their previous price target of $23.00.

AAR (NYSE:AIR) had its buy rating reissued by analysts at Truist Financial Corporation. Truist Financial Corporation currently has a $128.00 target price on the stock, up from their previous target price of $107.00.

Amprius Technologies (NYSE:AMPX) had its buy rating reissued by analysts at Roth Mkm. The firm currently has a $20.00 target price on the stock, up from their previous target price of $16.00.

ArriVent BioPharma (NASDAQ:AVBP) had its outperform rating reissued by analysts at Oppenheimer Holdings, Inc.. They currently have a $50.00 price target on the stock, up from their previous price target of $44.00.

Avantor (NYSE:AVTR) had its underweight rating reiterated by analysts at Barclays PLC. They currently have a $8.50 target price on the stock.

Brilliant Earth Group (NASDAQ:BRLT) had its neutral rating reiterated by analysts at B. Riley Financial, Inc.. They currently have a $1.50 price target on the stock, down from their previous price target of $3.00.

Certara (NASDAQ:CERT) had its equal weight rating reaffirmed by analysts at Barclays PLC. The firm currently has a $8.00 price target on the stock.

Traeger (NYSE:COOK) had its neutral rating reiterated by analysts at B. Riley Financial, Inc.. The firm currently has a $0.80 target price on the stock, down from their previous target price of $1.00.

Costco Wholesale (NASDAQ:COST) had its neutral rating reaffirmed by analysts at DA Davidson. The firm currently has a $1,000.00 price target on the stock.

Coterra Energy (NYSE:CTRA) was downgraded by analysts at Siebert Williams Shank from a buy rating to a hold rating.

Day One Biopharmaceuticals (NASDAQ:DAWN) had its hold rating reiterated by analysts at Needham & Company LLC.

Delek Logistics Partners (NYSE:DKL) had its neutral rating reaffirmed by analysts at Citigroup Inc.. They currently have a $52.00 price target on the stock, up from their previous price target of $47.00.

Enhabit (NYSE:EHAB) had its hold rating reaffirmed by analysts at TD Cowen. The firm currently has a $13.80 price target on the stock, up from their previous price target of $12.00.

Samsara (NYSE:IOT) had its overweight rating reiterated by analysts at Piper Sandler. The firm currently has a $39.00 price target on the stock, up from their previous price target of $37.00.

Kroger (NYSE:KR) had its buy rating reissued by analysts at Roth Mkm. Roth Mkm currently has a $78.00 target price on the stock, up from their previous target price of $75.00.

Magnolia Oil & Gas (NYSE:MGY) was downgraded by analysts at Siebert Williams Shank from a buy rating to a hold rating.

Marvell Technology (NASDAQ:MRVL) had its buy rating reaffirmed by analysts at B. Riley Financial, Inc.. They currently have a $135.00 target price on the stock, up from their previous target price of $130.00.

Strategy (NASDAQ:MSTR) had its buy rating reiterated by analysts at BTIG Research.

OptimizeRx (NASDAQ:OPRX) had its buy rating reaffirmed by analysts at B. Riley Financial, Inc.. B. Riley Financial, Inc. currently has a $11.00 target price on the stock, down from their previous target price of $28.00.

Pacific Biosciences of California (NASDAQ:PACB) had its underweight rating reiterated by analysts at Barclays PLC. They currently have a $1.50 price target on the stock, down from their previous price target of $2.00.

Tanger (NYSE:SKT) had its neutral rating reissued by analysts at Bank of America Corporation. The firm currently has a $39.00 target price on the stock.

Trade Desk (NASDAQ:TTD) had its underperform rating reissued by analysts at Wedbush. Wedbush currently has a $23.00 target price on the stock.

Warner Bros. Discovery (NASDAQ:WBD) was downgraded by analysts at Moffett Nathanson from a buy rating to a neutral rating. The firm currently has $31.00 target price on the stock.

Zealand Pharma A/S (OTCMKTS:ZLDPF) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald.

Zealand Pharma A/S (OTCMKTS:ZLDPF) had its market perform rating reissued by analysts at William Blair.